AbCellera Biologics Inc vs STMicroelectronics NV — how do they compare? AbCellera Biologics Inc trades at $8.98 (market cap $2.99B), while STMicroelectronics NV trades at $56 (market cap $49.21B). The key difference: STMicroelectronics NV is far larger — about 16.5× AbCellera Biologics Inc's market cap, and STMicroelectronics NV pays a 0.65% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | STM | |
|---|---|---|
Market Cap | $2.99B | $49.21B |
Sector | Health | Financials |
52-Week High | $9.76 | $79.91 |
52-Week Low | $2.78 | $21.20 |
Enterprise Value | $2.58B | $47.21B |
Dividend Yield | — | 0.65% |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →